Groundbreaking ‘Heart in a Box’ technology gets FDA approval

[KSTP-TV News, May 10, 2022]

Groundbreaking technology that will change how heart transplants are done nationwide has now received approval from the U.S. Food and Drug Administration. News of FDA approval has researchers involved in the clinical trials elated.

“It’s been it’s been a great journey,” said Dr. Benjamin Sun, surgical director for heart failure at the Minneapolis Heart Institute Foundation, a site included in the trial. “Now, the next part of it is how do we roll this out as a therapy? What do we think the penetration of this new therapy is to our patients? And how will it affect our program?"

Posted on May 11, 2022 in Minneapolis Heart Institute Foundation

Share this article